Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 29-Feb-24 4:05 PM View:  | Agios Pharmaceuticals, Inc. (AGIO) | 27-Feb-24 | Option Exercise | 69,329 | $31.64 | $2,193,570.00 | 15% 472.71K to 542.04K | |
| 29-Feb-24 4:05 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 27-Feb-24 | Option Sale | 69,329 | $34.67 | $2,403,590.00 | (13%) 542.04K to 472.71K | |
| 27-Feb-24 4:04 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 26-Feb-24 | Option Exercise | 20,411 | $31.64 | $645,804.00 | 4% 472.71K to 493.12K | |
| 27-Feb-24 4:04 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 26-Feb-24 | Option Sale | 20,411 | $33.19 | $677,441.00 | (4%) 493.12K to 472.71K | |
| 27-Feb-24 4:04 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 23-Feb-24 | Option Exercise | 47,731 | $31.64 | $1,510,210.00 | 10% 472.71K to 520.44K | |
| 27-Feb-24 4:04 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 23-Feb-24 | Option Sale | 47,731 | $33.05 | $1,577,510.00 | (9%) 520.44K to 472.71K | |
| 04-Jan-24 4:17 PM View: | Regeneron Pharmaceuticals I... (REGN) | 02-Jan-24 | Grant | 42 | -- | -- | 17% 0.24K to 0.28K | |
| 12-Sep-23 4:04 PM View: | Regeneron Pharmaceuticals I... (REGN) | 08-Sep-23 | Grant | 240 | -- | -- | 100% 0 to 0.24K | |
| 23-Jun-23 4:34 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 21-Jun-23 | Option Exercise | 4,975 | -- | -- | 1% 467.73K to 472.71K | |
| 05-Jun-23 6:04 PM View: | Denali Therapeutics Inc. (DNLI) | 01-Jun-23 | Grant | 4,216 | -- | -- | 6% 68.78K to 72.99K | |
| 05-Apr-23 4:03 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 03-Apr-23 | Option Exercise | 16,363 | $9.05 | $148,085.00 | 3% 467.73K to 484.1K | |
| 05-Apr-23 4:03 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 03-Apr-23 | Planned Option Sale | 16,363 | $22.85 | $373,895.00 | (3%) 484.1K to 467.73K | |
| 29-Mar-23 9:30 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 27-Mar-23 | Option Exercise | 20,000 | $9.05 | $181,000.00 | 4% 467.73K to 487.73K | |
| 29-Mar-23 9:30 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 27-Mar-23 | Planned Option Sale | 20,000 | $22.15 | $443,000.00 | (4%) 487.73K to 467.73K | |
| 15-Mar-23 5:11 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 13-Mar-23 | Option Exercise | 20,000 | $9.05 | $181,000.00 | 4% 467.73K to 487.73K | |
| 15-Mar-23 5:11 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 13-Mar-23 | Planned Option Sale | 20,000 | $22.49 | $449,817.00 | (4%) 487.73K to 467.73K | |
| 01-Mar-23 4:06 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 27-Feb-23 | Option Exercise | 20,000 | $9.05 | $181,000.00 | 4% 467.73K to 487.73K | |
| 01-Mar-23 4:06 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 27-Feb-23 | Planned Option Sale | 20,000 | $25.37 | $507,400.00 | (4%) 487.73K to 467.73K | |
| 15-Feb-23 4:03 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 13-Feb-23 | Option Exercise | 20,000 | $9.05 | $181,000.00 | 4% 467.73K to 487.73K | |
| 15-Feb-23 4:03 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 13-Feb-23 | Planned Option Sale | 20,000 | $28.62 | $572,400.00 | (4%) 487.73K to 467.73K | |
| 01-Feb-23 4:04 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 30-Jan-23 | Option Exercise | 20,000 | $9.05 | $181,000.00 | 4% 467.73K to 487.73K | |
| 01-Feb-23 4:04 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 30-Jan-23 | Planned Option Sale | 20,000 | $29.33 | $586,578.00 | (4%) 487.73K to 467.73K | |
| 19-Jan-23 4:03 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 17-Jan-23 | Option Exercise | 20,000 | $9.05 | $181,000.00 | 4% 467.73K to 487.73K | |
| 19-Jan-23 4:03 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 17-Jan-23 | Planned Option Sale | 20,000 | $28.85 | $577,093.00 | (4%) 487.73K to 467.73K | |
| 06-Jun-22 8:09 PM View: | Denali Therapeutics Inc. (DNLI) | 02-Jun-22 | Grant | 5,986 | -- | -- | 10% 62.79K to 68.78K | |
| 24-May-22 4:11 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 20-May-22 | Option Exercise | 1,585 | -- | -- | < 1% 466.15K to 467.73K | |
| 23-Feb-22 4:09 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 22-Feb-22 | Payment of Exercise | 758 | $29.08 | $22,042.60 | (< 1%) 466.91K to 466.15K | |
| 23-Feb-22 4:09 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 22-Feb-22 | Option Exercise | 2,775 | -- | -- | < 1% 464.13K to 466.91K | |
| 04-Jun-21 6:37 PM View: | Denali Therapeutics Inc. (DNLI) | 02-Jun-21 | Grant | 2,074 | -- | -- | 3% 60.72K to 62.79K | |
| 03-Jun-21 8:57 PM View: | Denali Therapeutics Inc. (DNLI) | 01-Jun-21 | Option Exercise | 3,253 | -- | -- | 6% 57.46K to 60.72K | |
| 02-Jun-21 4:07 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 28-May-21 | Option Exercise | 1,686 | -- | -- | < 1% 462.44K to 464.13K | |
| 24-Feb-21 4:12 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 22-Feb-21 | Payment of Exercise | 821 | -- | -- | (< 1%) 463.27K to 462.44K | |
| 24-Feb-21 4:12 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 22-Feb-21 | Option Exercise | 2,774 | -- | -- | < 1% 460.49K to 463.27K | |
| 17-Feb-21 4:12 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 16-Feb-21 | Payment of Exercise | 2,540 | -- | -- | (< 1%) 463.03K to 460.49K | |
| 17-Feb-21 4:12 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 16-Feb-21 | Option Exercise | 8,125 | -- | -- | 2% 454.91K to 463.03K | |
| 23-Dec-20 9:52 PM View: | Denali Therapeutics Inc. (DNLI) | 21-Dec-20 | Market Sale (Planned) | 25,000 | $90.06 | $2,251,560.00 | (29%) 87.46K to 62.46K | |
| 23-Dec-20 9:52 PM View: | Denali Therapeutics Inc. (DNLI) | 21-Dec-20 | Market Sale (Planned) | 5,000 | $90.01 | $450,027.00 | (8%) 62.46K to 57.46K | |
| 13-Nov-20 5:13 PM View: | Denali Therapeutics Inc. (DNLI) | 12-Nov-20 | Market Sale (Planned) | 30,000 | $70.05 | $2,101,590.00 | (10%) 305.0K to 275.0K | |
| 12-Nov-20 4:21 PM View: | Denali Therapeutics Inc. (DNLI) | 10-Nov-20 | Market Sale (Planned) | 10,000 | $60.03 | $600,310.00 | (3%) 315.0K to 305.0K | |
| 06-Nov-20 5:53 PM View: | Denali Therapeutics Inc. (DNLI) | 04-Nov-20 | Market Sale (Planned) | 10,000 | $50.18 | $501,830.00 | (3%) 325.0K to 315.0K | |
| 22-Jun-20 4:27 PM View: | Bluebird Bio, Inc. (BLUE) | 18-Jun-20 | Grant | 1,656 | -- | -- | 32% 5.18K to 6.83K | |
| 25-Feb-20 4:25 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 24-Feb-20 | Payment of Exercise | 880 | $48.66 | $42,820.80 | (< 1%) 455.79K to 454.91K | 14% |
| 25-Feb-20 4:25 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 22-Feb-20 | Option Exercise | 2,775 | -- | -- | < 1% 453.01K to 455.79K | |
| 19-Feb-20 4:50 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 18-Feb-20 | Payment of Exercise | 2,534 | $52.01 | $131,793.00 | (< 1%) 455.55K to 453.01K | 20% |
| 19-Feb-20 4:50 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 16-Feb-20 | Option Exercise | 8,125 | -- | -- | 2% 447.42K to 455.55K | |
| 15-Nov-19 4:03 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 13-Nov-19 | Private Purchase | 8,064 | $31.00 | $249,984.00 | 2% 439.36K to 447.42K | |
| 10-Jun-19 4:32 PM View: | Bluebird Bio, Inc. (BLUE) | 06-Jun-19 | Grant | 1,000 | -- | -- | 24% 4.18K to 5.18K | |
| 20-Feb-19 4:07 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 19-Feb-19 | Payment of Exercise | 2,471 | $58.03 | $143,392.00 | (< 1%) 441.83K to 439.36K | 28% |
| 20-Feb-19 4:07 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 16-Feb-19 | Option Exercise | 8,125 | -- | -- | 2% 433.7K to 441.83K | |
| 19-Nov-18 4:01 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 08-Nov-18 | Gift | 1,000 | -- | -- | (< 1%) 434.7K to 433.7K |